The lung cancer microenvironment and the lung microbioma: cross or cease fire?

H. Slevogt (Berlin, Germany)

Source: Virtual Congress 2020 – Exciting new developments in lung cancer screening, diagnostics and treatment
Disease area: -

Webcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Slevogt (Berlin, Germany). The lung cancer microenvironment and the lung microbioma: cross or cease fire?. Virtual Congress 2020 – Exciting new developments in lung cancer screening, diagnostics and treatment

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Why can initial treatment of localised lung cancer fail?
Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent
Year: 2007


Intersections of lung progenitor cells, lung disease and lung cancer
Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017
Year: 2017



Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007


How do lung cancer patients die?
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Targeted therapies for lung cancer: how did the game begin?
Source: Breathe 2016; 12: 177-179
Year: 2016


“Scar-cinoma”: viewing the fibrotic lung mesenchymal cell in the context of cancer biology
Source: Eur Respir J 2016; 47:1842-1854
Year: 2016



Lung cancer or cancer of the lung: a view from the bridge
Source: Virtual Congress 2020 – Lung cancer or cancer of the lung
Year: 2020

Can resistive-breathing injure the lung?
Source: Annual Congress 2013 –"Liaisons Dangereuses": the lung and other organs
Year: 2013


Stem cells and lung cancer treatment: any hope?
Source: International Congress 2016 – Molecular footprints in lung cancer diagnosis and management
Year: 2016


Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Year: 2009

Outcome after single lung transplantation: what about cancer of the native lung?
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009


Can the brain injure the lung?
Source: Annual Congress 2013 –"Liaisons Dangereuses": the lung and other organs
Year: 2013


Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006


Surgically treated lung cancer patients: do they all smoke and would they all have been detected with lung cancer screening?
Source: ERJ Open Res, 4 (3) 00001-2018; 10.1183/23120541.00001-2018
Year: 2018



Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020